Founded in 2012, InnoSer is an innovative and dynamic contract research organization (CRO) supporting discovery and preclinical development of drugs from its facilities in Belgium and the Netherlands.
InnoSer’s mission is to accelerate drug development by offering well characterized and accurate near-patient research models and innovative CRO services.
These offerings include a proprietary PDX/O screening platform for oncology, a unique ADPKD mouse model for nephrology, and a fully characterized midbrain organoid model for Parkinson’s disease.
InnoSer also provides in vivo imaging, pathology and genetically engineered mouse model services including colony management, cryopreservation, and sanitation/rederivation.
A full-suite of (digital) pathology services are offered via InnoSer's sister company C-Path, and can be fully integrated to various study pipelines.
Want to know more about InnoSer or C-Path? Let's connect at our joint booth.